SET oncoprotein accumulation regulates transcription through DNA demethylation and histone hypoacetylation

Oncotarget

Volumn 8, Issue 16, 2017, Pages 26802-26818

  Almeida, Luciana O ^a,b   Neto, Marinaldo P C ^a   Sousa, Lucas O ^a   Tannous, Maryna A ^a   Curti, Carlos ^a   Leopoldino, Andreia M ^a,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

^c Centro de Terapia Celular   (Brazil)

Author keywords

Active DNA demethylation; Chromatin; Histone acetylation; HNSCC; SET protein

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; 5 METHYLCYTIDINE; CYTIDINE DERIVATIVE; DECITABINE; GENOMIC DNA; ONCOPROTEIN; PROTEIN SET; TRANSCRIPTION FACTOR; TRICHOSTATIN A; UNCLASSIFIED DRUG; CHAPERONE; DNA BINDING PROTEIN; HISTONE; SET PROTEIN, HUMAN;

ARTICLE; CHROMATIN; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; EMBRYO; EPIGENETICS; GENE EXPRESSION REGULATION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HISTONE ACETYLATION; HUMAN; HUMAN CELL; PHENOTYPE; PROMOTER REGION; TRANSCRIPTION REGULATION; UPREGULATION; ACETYLATION; BIOLOGICAL MODEL; GENE EXPRESSION PROFILING; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; NON SMALL CELL LUNG CANCER; TUMOR CELL LINE;

ACETYLATION; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DNA METHYLATION; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE CHAPERONES; HISTONES; HUMANS; MODELS, BIOLOGICAL; ONCOGENE PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 85017521525     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.15818     Document Type: Article

References (56)

1. Brait M, Sidransky D. Cancer epigenetics: above and beyond. Toxicol Mech Methods. 2011; 21:275-288
2. Glazer CA, Chang SS, Ha PK, Califano JA. Applying the molecular biology and epigenetics of head and neck cancer in everyday clinical practice. Oral Oncol. 2009; 45:440-446
3. Goll MG, Bestor TH. Eukaryotic cytosine methyltransferases. Annu Rev Biochem. 2005; 74:481-514
4. Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007; 128:683-692
5. Bhutani N, Burns DM, Blau HM. DNA demethylation dynamics. Cell. 2011; 146:866-872
6. Delatte B, Deplus R, Fuks F. Playing TETris with DNA modifications. EMBO J. 2014; 33:1198-1211
7. Reddy KL, Feinberg AP. Higher order chromatin organization in cancer. Semin Cancer Biol. 2013; 23:109-115
8. Kouzarides T. Chromatin modifications and their function. Cell. 2007; 128:693-705
9. Patel V, Hood BL, Molinolo AA, Lee NH, Conrads TP, Braisted JC, Krizman DB, Veenstra TD, Gutkind JS. Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression. Clin Cancer Res. 2008; 14:1002-1014
10. Gamble MJ, Fisher RP. SET, PARP1 remove DEK from chromatin to permit access by the transcription machinery. Nat Struct Mol Biol. 2007; 14:548-555
11. Gamble MJ, Erdjument-Bromage H, Tempst P, Freedman LP, Fisher RP. The histone chaperone TAF-I/SET/INHAT is required for transcription in vitro of chromatin templates. Mol Cell Biol,. 2005; 25:797-807
12. Leung JW, Leitch A, Wood JL, Shaw-Smith C, Metcalfe K, Bicknell LS, Jackson AP, Chen J. SET nuclear oncogene associates with microcephalin/MCPH1 and regulates chromosome condensation. J Biol Chem. 2011; 286:21393-21400
13. Seo SB, McNamara P, Heo S, Turner A, Lane WS, Chakravarti D. Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell. 2001; 104:119-130
14. Cervoni N, Detich N, Seo SB, Chakravarti D, Szyf M. The oncoprotein Set/TAF-1beta, an inhibitor of histone acetyltransferase, inhibits active demethylation of DNA, integrating DNA methylation and transcriptional silencing. J Biol Chem. 2002; 277:25026-25031
15. Leopoldino AM, Squarize CH, Garcia CB, Almeida LO, Pestana CR, Sobral LM, Uyemura SA, Tajara EH, Silvio Gutkind J, Curti C. SET protein accumulates in HNSCC and contributes to cell survival: antioxidant defense, Akt phosphorylation and AVOs acidification. Oral Oncol. 2012; 48:1106-1113
16. Farrell AS, Allen-Petersen B, Daniel CJ, Wang X, Wang Z, Rodriguez S, Impey S, Oddo J, Vitek MP, Lopez C, Christensen DJ, Sheppard B, Sears RC. Targeting inhibitors of the tumor suppressor PP2A for the treatment of pancreatic cancer. Mol Cancer Res. 2014; 12:924-939
17. Li M, Makkinje A, Damuni Z. The myeloid leukemiaassociated protein SET is a potent inhibitor of protein phosphatase 2A. J Biol Chem. 1996; 271:11059-11062
18. Hu X, Garcia C, Fazli L, Gleave M, Vitek MP, Jansen M, Christensen D, Mulholland DJ. Inhibition of Pten deficient Castration Resistant Prostate Cancer by Targeting of the SET-PP2A Signaling axis. Sci Rep. 2015; 5:15182
19. Liu GP, Wei W, Zhou X, Zhang Y, Shi HH, Yin J, Yao XQ, Peng CX, Hu J, Wang Q, Li HL, Wang JZ. I(PP2A) regulates p53 and Akt correlatively and leads the neurons to abort apoptosis. Neurobiol Aging. 2012; 33:254-264
20. Kelkar A, Deobagkar D. A novel method to assess the full genome methylation profile using monoclonal antibody combined with the high throughput based microarray approach. Epigenetics. 2009; 4:415-420
21. Gasche JA, Hoffmann J, Boland CR, Goel A. Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells. Int J Cancer. 2011; 129:1053-1063
22. Mosquera Orgueira A. Hidden among the crowd: differential DNA methylation-expression correlations in cancer occur at important oncogenic pathways. Front Genet. 2015; 6:163
23. Almeida LO, Goto RN, Pestana CR, Uyemura SA, Gutkind S, Curti C, Leopoldino AM. SET overexpression decreases cell detoxification efficiency: ALDH2 and GSTP1 are downregulated, DDR is impaired and DNA damage accumulates. FEBS J. 2012; 279:4615-4628
24. Kutney SN, Hong R, Macfarlan T, Chakravarti D. A signaling role of histone-binding proteins and INHAT subunits pp32 and Set/TAF-Ibeta in integrating chromatin hypoacetylation and transcriptional repression. J Biol Chem. 2004; 279:30850-30855
25. Law JA, Jacobsen SE. Establishing, maintaining and modifying DNA methylation patterns in plants and animals. Nat Rev Genet. 2010; 11:204-220
26. Wu H, Zhang Y. Reversing DNA methylation: mechanisms, genomics, and biological functions. Cell. 2014; 156:45-68
27. Xu WS, Parmigiani RB, Marks PA. Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene. 2007; 26:5541-5552
28. Vaissiere T, Sawan C, Herceg Z. Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat Res. 2008; 659:40-48
29. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001; 29:e45
30. Miller JL, Grant PA. The role of DNA methylation and histone modifications in transcriptional regulation in humans. Subcell Biochem. 2013; 61:289-317
31. Guo H, Reddy SA, Damuni Z. Purification and characterization of an autophosphorylation-activated protein serine threonine kinase that phosphorylates and inactivates protein phosphatase 2A. J Biol Chem. 1993; 268:11193-11198
32. Karetsou Z, Martic G, Tavoulari S, Christoforidis S, Wilm M, Gruss C, Papamarcaki T. Prothymosin alpha associates with the oncoprotein SET and is involved in chromatin decondensation. FEBS Lett. 2004; 577:496-500
33. Matsumoto K, Nagata K, Okuwaki M, Tsujimoto M. Histone-and chromatin-binding activity of template activating factor-I. FEBS Lett. 1999; 463:285-288
34. Karetsou Z, Martic G, Sflomos G, Papamarcaki T. The histone chaperone SET/TAF-Ibeta interacts functionally with the CREB-binding protein. Biochem Biophys Res Commun. 2005; 335:322-327
35. Dikshit RP, Gillio-Tos A, Brennan P, De Marco L, Fiano V, Martinez-Penuela JM, Boffetta P, Merletti F. Hypermethylation, risk factors, clinical characteristics, and survival in 235 patients with laryngeal and hypopharyngeal cancers. Cancer. 2007; 110:1745-1751
36. Smith IM, Mydlarz WK, Mithani SK, Califano JA. DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage. Int J Cancer. 2007; 121:1724-1728
37. Richards EJ. Quantitative epigenetics: DNA sequence variation need not apply. Genes Dev. 2009; 23:1601-1605
38. Kalverda B, Roling MD, Fornerod M. Chromatin organization in relation to the nuclear periphery. FEBS Lett. 2008; 582:2017-2022
39. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002; 16:6-21
40. Huang Y, Rao A. Connections between TET proteins and aberrant DNA modification in cancer. Trends Genet. 2014
41. Miremadi A, Oestergaard MZ, Pharoah PD, Caldas C. Cancer genetics of epigenetic genes. Hum Mol Genet. 2007; 16 Spec No 1:R28-49
42. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res. 1998; 72:141-196
43. Bakin AV, Curran T. Role of DNA 5-methylcytosine transferase in cell transformation by fos. Science. 1999; 283:387-390
44. Subramaniam D, Thombre R, Dhar A, Anant S. DNA methyltransferases: a novel target for prevention and therapy. Front Oncol. 2014; 4:80
45. Kohli RM, Zhang Y. TET enzymes, TDG and the dynamics of DNA demethylation. Nature. 2013; 502:472-479
46. Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G, Bonaldi T, Haydon C, Ropero S, Petrie K, Iyer NG, Perez-Rosado A, Calvo E, et al. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet. 2005; 37:391-400
47. Kondo Y, Shen L, Cheng AS, Ahmed S, Boumber Y, Charo C, Yamochi T, Urano T, Furukawa K, Kwabi-Addo B, Gold DL, Sekido Y, Huang TH, et al. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet. 2008; 40:741-750
48. Rose NR, Klose RJ. Understanding the relationship between DNA methylation and histone lysine methylation. Biochim Biophys Acta. 2014; 1839:1362-1372
49. Issa JP. DNA methylation as a clinical marker in oncology. J Clin Oncol. 2012; 30:2566-2568
50. Raynal NJ, Si J, Taby RF, Gharibyan V, Ahmed S, Jelinek J, Estecio MR, Issa JP. DNA methylation does not stably lock gene expression but instead serves as a molecular mark for gene silencing memory. Cancer Res. 2012; 72:1170-1181
51. Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011; 21:381-395
52. Zhang T, Cooper S, Brockdorff N. The interplay of histone modifications-writers that read. EMBO Rep. 2015; 16:1467-1481
53. Yeudall WA, Crawford RY, Ensley JF, Robbins KC. MTS1/CDK4I is altered in cell lines derived from primary and metastatic oral squamous cell carcinoma. Carcinogenesis. 1994; 15:2683-2686
54. Castilho RM, Squarize CH, Leelahavanichkul K, Zheng Y, Bugge T, Gutkind JS. Rac1 is required for epithelial stem cell function during dermal and oral mucosal wound healing but not for tissue homeostasis in mice. PloS one. 2010; 5:e10503
55. Habib M, Fares F, Bourgeois CA, Bella C, Bernardino J, Hernandez-Blazquez F, de Capoa A, Niveleau A. DNA global hypomethylation in EBV-transformed interphase nuclei. Exp Cell Res. 1999; 249:46-53
56. Squarize CH, Castilho RM, Sriuranpong V, Pinto DS Jr. and Gutkind JS. Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma. Neoplasia. 2006; 8:733-746